Meningococcal Disease and Its Management in Children

Overview

Journal BMJ

Specialty General Medicine

Date 2006 Sep 30

PMID 17008668

Citations 12

Authors

C Anthony Hart

Alistair P J Thomson

Affiliations

Soon will be listed here.

Citing Articles

Exploring the Health-Related Quality of Life and the Lived Experience of Adolescents Following Invasive Meningococcal Disease.

McMillan M, McDonough J, Angliss M, Buttery J, Saunders L, Mathew S Healthcare (Basel). 2024; 12(11).

PMID: 38891151 PMC: 11172222. DOI: 10.3390/healthcare12111075.

Meningococcemia in an 11 Months Old Infant.

Shrestha R, Karki S, Khadka M, Sapkota S, Timilsina B, Khadka S Case Rep Infect Dis. 2023; 2023:8951318.

PMID: 36936066 PMC: 10017207. DOI: 10.1155/2023/8951318.

Nonspecific symptoms dominate at first contact to emergency healthcare services among cases with invasive meningococcal disease.

Hovmand N, Christensen H, Lundbo L, Sandholdt H, Kronborg G, Darso P BMC Fam Pract. 2021; 22(1):240.

PMID: 34847878 PMC: 8630890. DOI: 10.1186/s12875-021-01585-8.

Evaluating the effectiveness of the 4CMenB vaccine against invasive meningococcal disease and gonorrhoea in an infant, child and adolescent program: protocol.

Marshall H, Andraweera P, Wang B, McMillan M, Koehler A, Lally N Hum Vaccin Immunother. 2021; 17(5):1450-1454.

PMID: 33428528 PMC: 8078704. DOI: 10.1080/21645515.2020.1827614.

[Hemorrhagic skin lesions associated with infections].

Elling R, Hufnagel M, Henneke P Monatsschr Kinderheilkd. 2020; 160(6):545-555.

PMID: 32226155 PMC: 7095866. DOI: 10.1007/s00112-012-2633-5.

References

Derkx B, Wittes J, McCloskey R . Randomized, placebo-controlled trial of HA-1A, a human monoclonal antibody to endotoxin, in children with meningococcal septic shock. European Pediatric Meningococcal Septic Shock Trial Study Group. Clin Infect Dis. 2000; 28(4):770-7. DOI: 10.1086/515184. View

Gray S, Trotter C, Ramsay M, Guiver M, Fox A, Borrow R . Epidemiology of meningococcal disease in England and Wales 1993/94 to 2003/04: contribution and experiences of the Meningococcal Reference Unit. J Med Microbiol. 2006; 55(Pt 7):887-896. DOI: 10.1099/jmm.0.46288-0. View

Fellick J, Sills J, Marzouk O, Hart C, Cooke R, Thomson A . Neurodevelopmental outcome in meningococcal disease: a case-control study. Arch Dis Child. 2001; 85(1):6-11. PMC: 1718841. DOI: 10.1136/adc.85.1.6. View

Richards C, Thimm A, Clark J, Thomson A, Newton T, Riordan F . The management of fever and petechiae: collaborative studies are needed. Arch Dis Child. 2001; 85(2):172. PMC: 1718865. DOI: 10.1136/adc.85.2.172a. View

WELLS L, Smith J, Weston V, Collier J, Rutter N . The child with a non-blanching rash: how likely is meningococcal disease?. Arch Dis Child. 2001; 85(3):218-22. PMC: 1718924. DOI: 10.1136/adc.85.3.218. View

Hackett S, Thomson A, Hart C . Cytokines, chemokines and other effector molecules involved in meningococcal disease. J Med Microbiol. 2001; 50(10):847-859. DOI: 10.1099/0022-1317-50-10-847. View

Thorburn K, Baines P, Thomson A, Hart C . Mortality in severe meningococcal disease. Arch Dis Child. 2001; 85(5):382-5. PMC: 1718982. DOI: 10.1136/adc.85.5.382. View

Carrol E, Thomson A, Hart C . New therapies and vaccines for meningococcal disease. Expert Opin Investig Drugs. 2002; 10(8):1487-500. DOI: 10.1517/13543784.10.8.1487. View

Hackett S, Guiver M, Marsh J, Sills J, Thomson A, Kaczmarski E . Meningococcal bacterial DNA load at presentation correlates with disease severity. Arch Dis Child. 2002; 86(1):44-6. PMC: 1719043. DOI: 10.1136/adc.86.1.44. View

10.

Hackett S, Carrol E, Guiver M, Marsh J, Sills J, Thomson A . Improved case confirmation in meningococcal disease with whole blood Taqman PCR. Arch Dis Child. 2002; 86(6):449-52. PMC: 1762989. DOI: 10.1136/adc.86.6.449. View

11.

Molesworth A, Thomson M, Connor S, Cresswell M, Morse A, Shears P . Where is the meningitis belt? Defining an area at risk of epidemic meningitis in Africa. Trans R Soc Trop Med Hyg. 2002; 96(3):242-9. DOI: 10.1016/s0035-9203(02)90089-1. View

12.

Riordan F, Marzouk O, Thomson A, Sills J, Hart C . Prospective validation of the Glasgow Meningococcal Septicaemia Prognostic Score. Comparison with other scoring methods. Eur J Pediatr. 2002; 161(10):531-7. DOI: 10.1007/s00431-002-1024-7. View

13.

Pathan N, Sandiford C, Harding S, Levin M . Characterization of a myocardial depressant factor in meningococcal septicemia. Crit Care Med. 2002; 30(10):2191-8. DOI: 10.1097/00003246-200210000-00003. View

14.

Kvalsvig A, Unsworth D . The immunopathogenesis of meningococcal disease. J Clin Pathol. 2003; 56(6):417-22. PMC: 1769980. DOI: 10.1136/jcp.56.6.417. View

15.

Yazdankhah S, Caugant D . Neisseria meningitidis: an overview of the carriage state. J Med Microbiol. 2004; 53(Pt 9):821-832. DOI: 10.1099/jmm.0.45529-0. View

16.

Marzouk O, Thomson A, Sills J, Hart C, Harris F . Features and outcome in meningococcal disease presenting with maculopapular rash. Arch Dis Child. 1991; 66(4):485-7. PMC: 1792978. DOI: 10.1136/adc.66.4.485. View

17.

Riordan F, Thomson A, Sills J, Hart C . Who spots the spots? Diagnosis and treatment of early meningococcal disease in children. BMJ. 1996; 313(7067):1255-6. PMC: 2352534. DOI: 10.1136/bmj.313.7067.1255. View

18.

Correia J, Hart C . Meningococcal disease. Clin Evid. 2005; (12):1164-81. View

19.

Ninis N, Phillips C, Bailey L, Pollock J, Nadel S, Britto J . The role of healthcare delivery in the outcome of meningococcal disease in children: case-control study of fatal and non-fatal cases. BMJ. 2005; 330(7506):1475. PMC: 558454. DOI: 10.1136/bmj.330.7506.1475. View

20.

Makwana N, Baines P . Myocardial dysfunction in meningococcal septic shock. Curr Opin Crit Care. 2005; 11(5):418-23. DOI: 10.1097/01.ccx.0000176699.51456.13. View